Carsten Thiel has been a leading expert in biopharmaceuticals for over twenty years. An ethical anomaly in his field, Thiel believes that one can be both ethical and profitable within the field of biopharmaceuticals. With this outlook, Thiel has been able to maximize both profits and helping patients get the medicine they need.
Enamored with science from a young age as a student in his native Germany, Thiel has always looked to DNA as a means of treating and curing disease. While he has a background in medicine, Thiel made his mark in the pharmaceutical world and made a name for himself in multiple pharmaceutical firms.
On the topic of the coronavirus, Carsten Thiel estimates that over half of the socially active, those who have to frequently leave their homes, will become infected. The cause for concern is over what exact period of time the infections will happen. Thiel believes that there are a lot of common misconceptions about the existence of the virus, and claims that many of us are either overreacting or underreacting to the pandemic.
One of the biggest issues as far as Thiel is concerned is an adequate amount of medical equipment. In Italy, there was a shortage of medical supplies and a limited hospital capacity, which may have been a factor in the surge of deaths. Read This Article for more information.
Thiel remains hopeful that several biotechnology firms including APEIRON in Europe and Johnson and Johnson in America, will work well in tandem to create treatments and/or a vaccine. He is the president of EUSA Pharma, a biotechnology firm that prides itself on making medicine quickly available to its patients.
Carsten is an invaluable asset in the fight against coronavirus, and urges biotech firms in countries all around the world to work together to fight back against the pandemic.
Additional reference: https://newswire.net/newsroom/blog-post/00114589-big-pharma-cares-carsten-thiel-s-philanthropic-and-ethical-contributions.html